92 related articles for article (PubMed ID: 19243853)
1. Generation of cytotoxicity against hepatitis delta virus genotypes and quasispecies by epitope modification.
Huang YH; Wu JC; Peng WL; Huo TI; Shih HH; Lan KH; Su CW; Lee SD
J Hepatol; 2009 Apr; 50(4):779-88. PubMed ID: 19243853
[TBL] [Abstract][Full Text] [Related]
2. Amino Acid Substitutions within HLA-B*27-Restricted T Cell Epitopes Prevent Recognition by Hepatitis Delta Virus-Specific CD8
Karimzadeh H; Kiraithe MM; Kosinska AD; Glaser M; Fiedler M; Oberhardt V; Salimi Alizei E; Hofmann M; Mok JY; Nguyen M; van Esch WJE; Budeus B; Grabowski J; Homs M; Olivero A; Keyvani H; Rodríguez-Frías F; Tabernero D; Buti M; Heinold A; Alavian SM; Bauer T; Schulze Zur Wiesch J; Raziorrouh B; Hoffmann D; Smedile A; Rizzetto M; Wedemeyer H; Timm J; Antes I; Neumann-Haefelin C; Protzer U; Roggendorf M
J Virol; 2018 Jul; 92(13):. PubMed ID: 29669837
[TBL] [Abstract][Full Text] [Related]
3. Human CD4+ T-cell response to hepatitis delta virus: identification of multiple epitopes and characterization of T-helper cytokine profiles.
Nisini R; Paroli M; Accapezzato D; Bonino F; Rosina F; Santantonio T; Sallusto F; Amoroso A; Houghton M; Barnaba V
J Virol; 1997 Mar; 71(3):2241-51. PubMed ID: 9032359
[TBL] [Abstract][Full Text] [Related]
4. Interdisciplinary analysis of HIV-specific CD8+ T cell responses against variant epitopes reveals restricted TCR promiscuity.
Hoof I; Pérez CL; Buggert M; Gustafsson RK; Nielsen M; Lund O; Karlsson AC
J Immunol; 2010 May; 184(9):5383-91. PubMed ID: 20363973
[TBL] [Abstract][Full Text] [Related]
5. Genetic immunization and comprehensive screening approaches in HLA-A2 transgenic mice lead to the identification of three novel epitopes in hepatitis C virus NS3 antigen.
Martin P; Parroche P; Chatel L; Barretto C; Beck A; Trépo C; Bain C; Lone YC; Inchauspé G; Fournillier A
J Med Virol; 2004 Nov; 74(3):397-405. PubMed ID: 15368525
[TBL] [Abstract][Full Text] [Related]
6. Identification of novel HLA-A*0201-restricted CD8+ T-cell epitopes on hepatitis delta virus.
Huang YH; Tao MH; Hu CP; Syu WJ; Wu JC
J Gen Virol; 2004 Oct; 85(Pt 10):3089-3098. PubMed ID: 15448372
[TBL] [Abstract][Full Text] [Related]
7. Mutations in Hepatitis D Virus Allow It to Escape Detection by CD8
Karimzadeh H; Kiraithe MM; Oberhardt V; Salimi Alizei E; Bockmann J; Schulze Zur Wiesch J; Budeus B; Hoffmann D; Wedemeyer H; Cornberg M; Krawczyk A; Rashidi-Alavijeh J; Rodríguez-Frías F; Casillas R; Buti M; Smedile A; Alavian SM; Heinold A; Emmerich F; Panning M; Gostick E; Price DA; Timm J; Hofmann M; Raziorrouh B; Thimme R; Protzer U; Roggendorf M; Neumann-Haefelin C
Gastroenterology; 2019 May; 156(6):1820-1833. PubMed ID: 30768983
[TBL] [Abstract][Full Text] [Related]
8. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection.
Nayersina R; Fowler P; Guilhot S; Missale G; Cerny A; Schlicht HJ; Vitiello A; Chesnut R; Person JL; Redeker AG; Chisari FV
J Immunol; 1993 May; 150(10):4659-71. PubMed ID: 7683326
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis D Virus-Specific CD8
Kefalakes H; Koh C; Sidney J; Amanakis G; Sette A; Heller T; Rehermann B
Gastroenterology; 2019 May; 156(6):1805-1819.e9. PubMed ID: 30664876
[TBL] [Abstract][Full Text] [Related]
10. Pro-205 of large hepatitis delta antigen and Pro-62 of major hepatitis B surface antigen influence the assembly of different genotypes of hepatitis D virus.
Shih HH; Shih C; Wang HW; Su CW; Sheen IJ; Wu JC
J Gen Virol; 2010 Apr; 91(Pt 4):1004-12. PubMed ID: 19940060
[TBL] [Abstract][Full Text] [Related]
11. A novel HLA-A2-restricted CTL epitope of tumor-associated antigen L6 can inhibit tumor growth in vivo.
Tu SH; Huang HI; Lin SI; Liu HY; Sher YP; Chiang SK; Chong P; Roffler S; Tseng GC; Chen HW; Liu SJ
J Immunother; 2012 Apr; 35(3):235-44. PubMed ID: 22421941
[TBL] [Abstract][Full Text] [Related]
12. Functional assays of HLA A2-restricted epitope variant of latent membrane protein 1 (LMP-1) of Epstein-Barr virus in nasopharyngeal carcinoma of Southern China and Taiwan.
Lin HJ; Cherng JM; Hung MS; Sayion Y; Lin JC
J Biomed Sci; 2005 Dec; 12(6):925-36. PubMed ID: 16307312
[TBL] [Abstract][Full Text] [Related]
13. Relation between viral fitness and immune escape within the hepatitis C virus protease.
Söderholm J; Ahlén G; Kaul A; Frelin L; Alheim M; Barnfield C; Liljeström P; Weiland O; Milich DR; Bartenschlager R; Sällberg M
Gut; 2006 Feb; 55(2):266-74. PubMed ID: 16105887
[TBL] [Abstract][Full Text] [Related]
14. Highly conserved pattern of recognition of influenza A wild-type and variant CD8+ CTL epitopes in HLA-A2+ humans and transgenic HLA-A2+/H2 class I-deficient mice.
Hu N; D'Souza C; Cheung H; Lang H; Cheuk E; Chamberlain JW
Vaccine; 2005 Nov; 23(45):5231-44. PubMed ID: 16099553
[TBL] [Abstract][Full Text] [Related]
15. Autoantigen recognition by human CD8 T cell clones: enhanced agonist response induced by altered peptide ligands.
Dressel A; Chin JL; Sette A; Gausling R; Höllsberg P; Hafler DA
J Immunol; 1997 Nov; 159(10):4943-51. PubMed ID: 9366420
[TBL] [Abstract][Full Text] [Related]
16. Identification of an enhancer agonist cytotoxic T lymphocyte peptide from human carcinoembryonic antigen.
Zaremba S; Barzaga E; Zhu M; Soares N; Tsang KY; Schlom J
Cancer Res; 1997 Oct; 57(20):4570-7. PubMed ID: 9377571
[TBL] [Abstract][Full Text] [Related]
17. CTL responses of HLA-A2.1-transgenic mice specific for hepatitis C viral peptides predict epitopes for CTL of humans carrying HLA-A2.1.
Shirai M; Arichi T; Nishioka M; Nomura T; Ikeda K; Kawanishi K; Engelhard VH; Feinstone SM; Berzofsky JA
J Immunol; 1995 Mar; 154(6):2733-42. PubMed ID: 7533182
[TBL] [Abstract][Full Text] [Related]
18. DNA-Based immunization produces Th1 immune responses to hepatitis delta virus in a mouse model.
Huang YH; Wu JC; Tao MH; Syu WJ; Hsu SC; Chi WK; Chang FY; Lee SD
Hepatology; 2000 Jul; 32(1):104-10. PubMed ID: 10869296
[TBL] [Abstract][Full Text] [Related]
19. Protein-peptide arrays for detection of specific anti-hepatitis D virus (HDV) genotype 1, 6, and 8 antibodies among HDV-infected patients by surface plasmon resonance imaging.
Villiers MB; Cortay JC; Cortès S; Bloquel B; Brichler S; Brakha C; Kay A; Falah N; Zoulim F; Marquette C; Marche PN; Dény P
J Clin Microbiol; 2015 Apr; 53(4):1164-71. PubMed ID: 25631795
[TBL] [Abstract][Full Text] [Related]
20. Varied immunity generated in mice by DNA vaccines with large and small hepatitis delta antigens.
Huang YH; Wu JC; Hsu SC; Syu WJ
J Virol; 2003 Dec; 77(24):12980-5. PubMed ID: 14645554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
